Journal of pancreatic cancer Journal

Overview

publication venue for

A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer.. 5. 2019

Identity

ISO Abbreviation

J Pancreat Cancer

Linking ISSN

2475-3246

Electronic International Standard Serial Number (EISSN)

2475-3246